Idiopathic Pulmonary Fibrosis clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.
Orange, California and other locations
Our lead scientists for Idiopathic Pulmonary Fibrosis research studies include Huawei Dong.
Last updated: